J. Mark Lievonen
Director
biotechnology
Oncolytics Biotech
Germany
Biography
J. Mark Lievonen is an Independent Director of Oncolytics Biotech Inc., since April 5, 2004. He is President of Sanofi Pasteur Limited, a vaccine development, manufacturing and marketing company, since October 1998. Mr. Lievonen serves on a number of industry and not-for-profit boards including Rx&D, BIOTECanada, the Ontario Institute for Cancer Research and York University, and is a past Chair of BIOTECanada and the Ontario Genomics Institute.
Research Interest
biotechnology vaccine development
